Vernakalant
Clinically reviewed by MedNext Clinical Team. Last reviewed 1 January 2026. See our editorial policy and correction policy.
Indications
- Rapid conversion of recent onset atrial fibrillation to sinus rhythm (specialist supervision in hospital)
Safety Information
Cautions
Haemodynamically stable patients with congestive heart failure (increased risk of hypotension and ventricular arrhythmia); patients receiving oral anti-arrhythmics (class I or III) (risk of atrial flu
Side Effects
Full side effect profile available in the MedNext app.
Full safety information, contraindications, and dosing available in the MedNext app.
Brand Names
Get the Full Monograph
Complete dosing, interactions, contraindications, side effects, and more for Vernakalant.
Download Free — 7-Day TrialNo credit card required
In the MedNext App
- Complete dosing regimens
- Full interaction details & severity
- AI-powered drug search
- All 1 brand names
- Dosing calculators
- CME/CPD tracking
- 40 language support
- Offline access
Related drugs
Explore other drugs in the same clinical area or patient population.
Abacavir
Not classified · 18 interactions
Abacavir With Dolutegravir And Lamivudine
Not classified · 0 interactions
Abacavir With Lamivudine
Not classified · 49 interactions
Abacavir With Lamivudine And Zidovudine
Not classified · 0 interactions
Abaloparatide
Not classified · 5 interactions
Abatacept
Not classified · 13 interactions
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare professional before making clinical decisions. Verify all drug information with current clinical guidelines.
Access all 2866 drugs in the MedNext app
Complete monographs, AI-powered search, interaction checker, dosing calculators, and CME tracking — in 40 languages.
Download MedNext — Free 7-Day Trial